483 Cambrex Karlskoga AB May 2016

483 Cambrex Karlskoga AB May 2016

Nicholas Paulin FDA$119.00 - Available Now

FDA investigators audited the Cambrex Karlskoga AB - Karlskoga, Sweden facility and issued inspectional observations (via FDA 483) on 27 May 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 27 May 2016
  • Location: Karlskoga, Sweden
  • FEI: 3001686607
Add To Cart